Garabed Eknoyan

47.2k total citations · 8 hit papers
252 papers, 23.8k citations indexed

About

Garabed Eknoyan is a scholar working on Nephrology, History and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Garabed Eknoyan has authored 252 papers receiving a total of 23.8k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Nephrology, 33 papers in History and 32 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Garabed Eknoyan's work include Dialysis and Renal Disease Management (57 papers), Chronic Kidney Disease and Diabetes (27 papers) and History of Medicine Studies (25 papers). Garabed Eknoyan is often cited by papers focused on Dialysis and Renal Disease Management (57 papers), Chronic Kidney Disease and Diabetes (27 papers) and History of Medicine Studies (25 papers). Garabed Eknoyan collaborates with scholars based in United States, Canada and Belgium. Garabed Eknoyan's co-authors include Andrew S. Levey, Josef Coresh, Adeera Levin, Nathan W. Levin, Norbert Lameire, Tom Greene, Brad C. Astor, Ethan M. Balk, Annamaria T. Kausz and Ronald J. Hogg and has published in prestigious journals such as Science, New England Journal of Medicine and JAMA.

In The Last Decade

Garabed Eknoyan

245 papers receiving 22.5k citations

Hit Papers

National Kidney Foundatio... 1998 2026 2007 2016 2003 2005 2002 2006 2002 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification
    2003 3.6k citations Andrew S. Levey, Josef Coresh et al. Annals of Internal Medicine profile →
  2. Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
    2005 2.8k citations Andrew S. Levey, Kai‐Uwe Eckardt et al. Kidney International profile →
  3. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third national health and nutrition examination survey
    2002 2.2k citations Josef Coresh, Tom Greene et al. American Journal of Kidney Diseases profile →
  4. Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
    2006 1.4k citations Norbert Lameire, Garabed Eknoyan et al. Kidney International profile →
  5. Effect of Dialysis Dose and Membrane Flux in Maintenance Hemodialysis
    2002 1.3k citations Garabed Eknoyan, Gerald J. Beck et al. profile →
  6. Chronic kidney disease as a global public health problem: Approaches and initiatives – a position statement from Kidney Disease Improving Global Outcomes
    2007 1.1k citations Andrew S. Levey, Josef Coresh et al. Kidney International profile →
  7. Bone metabolism and disease in chronic kidney disease
    2003 997 citations Garabed Eknoyan, Adeera Levin et al. American Journal of Kidney Diseases profile →
  8. Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease
    1998 760 citations Andrew S. Levey, Garabed Eknoyan et al. American Journal of Kidney Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Garabed Eknoyan United States 57 13.4k 4.1k 3.7k 3.6k 2.3k 252 23.8k
Francesco Locatelli Italy 75 13.3k 1.0× 3.1k 0.8× 3.2k 0.8× 2.8k 0.8× 1.7k 0.7× 539 25.2k
Alejandro Castro Spain 18 8.2k 0.6× 5.0k 1.2× 3.1k 0.8× 3.0k 0.8× 2.8k 1.2× 62 20.5k
Nathan W. Levin United States 81 14.5k 1.1× 2.5k 0.6× 2.6k 0.7× 5.3k 1.5× 1.8k 0.8× 533 25.1k
Allan J. Collins United States 80 13.7k 1.0× 4.9k 1.2× 3.8k 1.0× 3.7k 1.0× 1.6k 0.7× 275 22.6k
Thomas H. Hostetter United States 68 10.7k 0.8× 3.6k 0.9× 2.9k 0.8× 2.2k 0.6× 2.9k 1.3× 187 20.1k
Paul E. de Jong Netherlands 73 13.0k 1.0× 8.6k 2.1× 4.1k 1.1× 3.2k 0.9× 4.4k 1.9× 311 24.9k
Paul W. Eggers United States 55 16.7k 1.2× 7.3k 1.8× 5.0k 1.3× 4.9k 1.4× 4.1k 1.8× 127 35.4k
Linda F. Fried United States 71 10.6k 0.8× 4.6k 1.1× 2.5k 0.7× 2.5k 0.7× 2.3k 1.0× 217 18.5k
Mark J. Sarnak United States 81 16.4k 1.2× 9.0k 2.2× 4.2k 1.1× 3.9k 1.1× 2.7k 1.2× 288 27.9k
David A. Roth United States 47 6.6k 0.5× 4.1k 1.0× 2.9k 0.8× 3.0k 0.8× 1.6k 0.7× 212 20.6k

Countries citing papers authored by Garabed Eknoyan

Since Specialization
Citations

This map shows the geographic impact of Garabed Eknoyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Garabed Eknoyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Garabed Eknoyan more than expected).

Fields of papers citing papers by Garabed Eknoyan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Garabed Eknoyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Garabed Eknoyan. The network helps show where Garabed Eknoyan may publish in the future.

Co-authorship network of co-authors of Garabed Eknoyan

This figure shows the co-authorship network connecting the top 25 collaborators of Garabed Eknoyan. A scholar is included among the top collaborators of Garabed Eknoyan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Garabed Eknoyan. Garabed Eknoyan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shoja, Mohammadali M., R. Shane Tubbs, Anand N. Bosmia, et al.. (2015). Herbal Diuretics in Medieval Persian and Arabic Medicine. The Journal of Alternative and Complementary Medicine. 21(6). 309–320. 6 indexed citations
2.
Truong, Luan D., Lillian W. Gaber, & Garabed Eknoyan. (2011). Obstructive Uropathy. Contributions to nephrology. 169. 311–326. 44 indexed citations
3.
Eknoyan, Garabed. (2009). Chronic kidney disease definition and classification: no need for a rush to judgment. Kidney International. 75(10). 1015–1018. 22 indexed citations
4.
Eknoyan, Garabed. (2009). The History of Dialysis: The Wonderful Apparatus of John Jacob Abel Called the “Artificial Kidney”. Seminars in Dialysis. 22(3). 287–296. 7 indexed citations
5.
Shoja, Mohammadali M., R. Shane Tubbs, Mohammadreza Ardalan, et al.. (2007). ANATOMY OF THE CRANIAL NERVES IN MEDIEVAL PERSIAN LITERATURE. Neurosurgery. 61(6). 1325–1331. 17 indexed citations
6.
Cheung, Alfred K., Michael V. Rocco, Guofen Yan, et al.. (2005). Serum β-2 Microglobulin Levels Predict Mortality in Dialysis Patients. Journal of the American Society of Nephrology. 17(2). 546–555. 312 indexed citations
7.
Greene, Tom, John T. Daugirdas, Thomas A. Depner, et al.. (2005). Association of Achieved Dialysis Dose with Mortality in the Hemodialysis Study. Journal of the American Society of Nephrology. 16(11). 3371–3380. 56 indexed citations
8.
Levey, Andrew S., K-U Eckardt, Joseph Coresh, et al.. (2005). 慢性腎臓疾患の定義と分類:腎臓疾患からの位置記載:全体的な転帰(KDIGO)の改善. Kidney International. 67(6). 2089–2100. 6 indexed citations
9.
Levey, Andrew S., Kai‐Uwe Eckardt, Yusuke Tsukamoto, et al.. (2005). Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney International. 67(6). 2089–2100. 2833 indexed citations breakdown →
10.
Levey, Andrew S., Josef Coresh, Ethan M. Balk, et al.. (2003). National Kidney Foundation Practice Guidelines for Chronic Kidney Disease. Annals of Internal Medicine. 139(2). 48 indexed citations
11.
Levin, Nathan W., et al.. (1997). National kidney foundation: dialysis outcome quality initiative-development of methodology for clinical practice guidelines. Nephrology Dialysis Transplantation. 12(10). 2060–2063. 23 indexed citations
12.
Truong, Luan D., et al.. (1996). Membranous glomerulonephritis associated with inflammatory demyelinating peripheral neuropathies. American Journal of Kidney Diseases. 27(2). 279–283. 26 indexed citations
13.
Eknoyan, Garabed & Shirley A. Riggs. (1986). Renal Involvement in Patients with Thrombotic Thrombocytopenic Purpura. American Journal of Nephrology. 6(2). 117–131. 30 indexed citations
14.
Eknoyan, Garabed & Sandra Sabatini. (1984). Renal papillary necrosis reappraised. Seminars in Nephrology. 4(1). 3–4.
15.
Eknoyan, Garabed. (1984). Analgesic nephrotoxicity and renal papillary necrosis. Seminars in Nephrology. 4(1). 65–76. 10 indexed citations
16.
Gorry, G. Anthony, et al.. (1978). Care for Hypertensives in a Neighborhood Clinic and a Hospital Outpatient Department. Journal of Ambulatory Care Management. 1(2). 41–52. 2 indexed citations
17.
Eknoyan, Garabed, et al.. (1976). Use of cardioactive drugs in acute myocardial infarction.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 5(1). 44–61. 1 indexed citations
18.
Olivero, Juan J., et al.. (1975). Mitigation of amphotericin B nephrotoxicity by mannitol.. BMJ. 1(5957). 550–551. 48 indexed citations
19.
Eknoyan, Garabed, et al.. (1973). Renal involvement in drug abuse.. PubMed. 132(6). 801–6. 27 indexed citations
20.
Eknoyan, Garabed, et al.. (1972). Renal morphological and immunological changes associated with acute viral hepatitis. Kidney International. 1(6). 413–419. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesco Locatelli Breakdown of academic impact, for papers by Alejandro Castro Breakdown of academic impact, for papers by Nathan W. Levin Breakdown of academic impact, for papers by Allan J. Collins Breakdown of academic impact, for papers by Thomas H. Hostetter Breakdown of academic impact, for papers by Paul E. de Jong Breakdown of academic impact, for papers by Paul W. Eggers Breakdown of academic impact, for papers by Linda F. Fried Breakdown of academic impact, for papers by Mark J. Sarnak Breakdown of academic impact, for papers by David A. Roth
Rankless by CCL
2026